loading...| Preferred Name |
pulmonary arterial hypertension |
|
| Synonyms |
Ayerza's Syndrome Hypertension, Pulmonary pulmonary hypertension Pulmonary hypertension, NOS pulmonary hypertension, primary, 1 Syndrome, Ayerza-Arrilaga Ayerzas Syndrome Syndrome, Ayerza HYPERTENSION PULM pulmonary arterial hypertension PHT - Pulmonary hypertension PULM HYPERTENSION Ayerza-Arrilaga Syndrome pulmonary hypertension (disorder) Ayerza Arrilaga Syndrome Ayerza Syndrome PAH PPH1 idiopathic pulmonary hypertension PPH PAH with overt features of venous/capillaries involvement PVOD/PCH |
|
| Definitions |
A syndrome with pathological changes in the pulmonary arteries and impaired PULMONARY CIRCULATION that can be the result of PULMONARY HYPERTENSION. Ayerza syndrome is characterized by slowly developing ASTHMA; BRONCHITIS; DYSPNEA; and CYANOSIS in association with POLYCYTHEMIA. Pulmonary arterial hypertension (PAH) is a group of diseases characterized by mean pulmonary artery pressure >20 mmHg and elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, have overt features of venous/capillary involvement (pulmonary veno-occlusive disease, PVOD/pulmonary capillary hemangiomatosis, PCH), induced by drug or toxin (drug-or toxin-induced PAH), or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease). Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. |
|
| ID |
http://www.ebi.ac.uk/efo/EFO_0001361 |
|
| closeMatch | ||
| database cross reference |
MedDRA:10064911 SCTID:11399002 Orphanet:182090 SNOMEDCT:70995007 MONDO:0015924 MESH:D000081029 OMIM:615371 UMLS:C2973725 MeSH:D006976 DOID:6432 GARD:7501 NCIt:C3120 NORD:1634 |
|
| exactMatch |
http://identifiers.org/mesh/D000081029 http://identifiers.org/snomedct/11399002 |
|
| gwas_trait |
true |
|
| has_narrow_synonym |
PAH with overt features of venous/capillaries involvement PVOD/PCH |
|
| has_related_synonym |
idiopathic pulmonary hypertension PPH |
|
| hasExactSynonym |
Ayerza's Syndrome Hypertension, Pulmonary pulmonary hypertension Pulmonary hypertension, NOS pulmonary hypertension, primary, 1 Syndrome, Ayerza-Arrilaga Ayerzas Syndrome Syndrome, Ayerza HYPERTENSION PULM pulmonary arterial hypertension PHT - Pulmonary hypertension PULM HYPERTENSION Ayerza-Arrilaga Syndrome pulmonary hypertension (disorder) Ayerza Arrilaga Syndrome Ayerza Syndrome PAH PPH1 |
|
| id |
EFO:0001361 |
|
| imported from | ||
| in subset |
http://purl.oboInOwllibrary.org/oboInOwl/mondo#rare http://purl.oboInOwllibrary.org/oboInOwl/mondo#gard_rare http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders http://purl.oboInOwllibrary.org/oboInOwl/mondo#nord_rare http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping http://purl.oboInOwllibrary.org/oboInOwl/mondo#orphanet_rare |
|
| label |
pulmonary arterial hypertension |
|
| notation |
EFO:0001361 |
|
| prefLabel |
pulmonary arterial hypertension |
|
| term editor |
James Malone |
|
| term tracker item | ||
| textual definition |
A syndrome with pathological changes in the pulmonary arteries and impaired PULMONARY CIRCULATION that can be the result of PULMONARY HYPERTENSION. Ayerza syndrome is characterized by slowly developing ASTHMA; BRONCHITIS; DYSPNEA; and CYANOSIS in association with POLYCYTHEMIA. Pulmonary arterial hypertension (PAH) is a group of diseases characterized by mean pulmonary artery pressure >20 mmHg and elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, have overt features of venous/capillary involvement (pulmonary veno-occlusive disease, PVOD/pulmonary capillary hemangiomatosis, PCH), induced by drug or toxin (drug-or toxin-induced PAH), or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease). Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. |
|
| subClassOf |